ShareValue scores for NEPHROPLUS.NSE: Valuation 27, Quality 53, Growth 54, Health 55.
NEPHROPLUS.NSENSE
NEPHROPLUS
₹694.65
(-0.29%)
NEPHROPLUS.NSENSE
NEPHROPLUS
₹694.65(-0.29%)
Loading chart...
Sentiment
Verdicts
Value:Overvalued
Quality:Moderate
Growth:Moderate
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
-6% to 10%
Rating
Trap Risk
Return
-6% to 10%
Valuation
27
Overvalued
Price vs Value
Quality
53
Moderate
Business Strength
Growth
54
Moderate
Revenue & Earnings
Health
55
Moderate
Financial Stability
Momentum
62
Bullish
Price Trend
Company Details
About
Nephrocare Health Services Limited provides dialysis healthcare services through a chain of kidney care clinics and dialysis centers in India, Uzbekistan, Nepal, and the Philippines. It provides In-clinic dialysis, dialysis on call, home hemodialysis, holiday dialysis, and dialysis on wheels services. The company was incorporated in 2009 and is based in Hyderabad, India.
Market Cap$69.85B
P/E Ratio82.5
Dividend YieldNone
Sector Rank#1739
Score Analysis
AI Investment Thesis
Data as of:Aug 18, 2026
|Last calculated:Aug 18, 2026